GKOS logo

Glaukos (GKOS) Company Overview

Profile

Full Name:

Glaukos Corporation

Sector:

Healthcare

Country:

United States

IPO:

June 25, 2015

Indexes:

Not included

Description:

Glaukos Corporation is a company specializing in ophthalmic medical technologies and pharmaceuticals, focusing on developing new methods for treating glaucoma, corneal diseases, and retinal diseases. The corporation was founded in 1998, with its headquarters in San Clemente, California. The company has developed micro-invasive glaucoma surgery (MIGS) as an alternative to traditional glaucoma treatment, and in 2012 launched its first MIGS device for sale. They have also developed a patented bioactivated pharmaceutical therapy for treating corneal disorders. Glaukos Corporation is involved in developing lines of surgical devices, pharmaceutical therapy, and implantable biosensors for treating the progression of glaucoma, corneal diseases such as keratoconus, dry eye, and a variety of other conditions.

Key Details

Price

$117.01

Annual Revenue

$383.48 M(+21.85% YoY)

Annual EPS

-$2.77(+0.36% YoY)

Annual ROE

-23.83%

Beta

1.37

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 20, 2025

Recent annual earnings:

Feb 20, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 21, 25 Wells Fargo
Overweight
Feb 21, 25 Needham
Buy
Feb 19, 25 Mizuho
Outperform
Jan 27, 25 Piper Sandler
Overweight
Dec 31, 24 Stifel
Buy
Dec 18, 24 Truist Securities
Buy
Dec 11, 24 Wells Fargo
Overweight
Dec 11, 24 Citigroup
Buy
Dec 6, 24 UBS
Buy
Dec 2, 24 Stifel
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Glaukos?
  • Does Glaukos pay dividends?
  • What sector is Glaukos in?
  • What industry is Glaukos in?
  • What country is Glaukos based in?
  • When did Glaukos go public?
  • Is Glaukos in the S&P 500?
  • Is Glaukos in the NASDAQ 100?
  • Is Glaukos in the Dow Jones?
  • When was Glaukos's last earnings report?
  • When does Glaukos report earnings?
  • Should I buy Glaukos stock now?

What is the ticker symbol for Glaukos?

The ticker symbol for Glaukos is NYSE:GKOS

Does Glaukos pay dividends?

No, Glaukos does not pay dividends

What sector is Glaukos in?

Glaukos is in the Healthcare sector

What industry is Glaukos in?

Glaukos is in the Medical Devices industry

What country is Glaukos based in?

Glaukos is headquartered in United States

When did Glaukos go public?

Glaukos's initial public offering (IPO) was on June 25, 2015

Is Glaukos in the S&P 500?

No, Glaukos is not included in the S&P 500 index

Is Glaukos in the NASDAQ 100?

No, Glaukos is not included in the NASDAQ 100 index

Is Glaukos in the Dow Jones?

No, Glaukos is not included in the Dow Jones index

When was Glaukos's last earnings report?

Glaukos's most recent earnings report was on Feb 20, 2025

When does Glaukos report earnings?

The next expected earnings date for Glaukos is May 1, 2025

Should I buy Glaukos stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions